Ion coupling, permeation, and regulation in glutamate transporters
- Institution
- WEILL MEDICAL COLL OF CORNELL UNIV, NY
- Principal investigator
- Olga Boudker
- Funding
- $523K
- Duration
- 2024–2027
Moonbase score
Still being scored
Abstract
Glutamate is the primary excitatory neurotransmitter in the human brain, responsible for cognition, memory formation, learning, and pain signaling, among other functions. Two families of integral membrane glutamate transporters are essential players in glutamatergic neurotransmission. The VGLUT family loads glutamate into the synaptic vesicles, and the EAAT family removes the neurotransmitter from the synaptic cleft following neurotransmission. The dysregulation of these transporters under pathologic conditions and neurologic disorders disrupts glutamate homeostasis leading to aberrant neurotransmission, glutamate excitotoxicity, and neuronal death. Ions play crucial roles in the function of these transporters. Electrochemical gradients of ions power the concentrative glutamate uptake and regulate transporters. In addition, transporters can conduct ions in a manner uncoupled from the neurotransmitter uptake, modulating electrochemical trans-membrane gradients. This grant proposal aims to understand the mechanism and evolution of ion-coupling mechanisms, mechanisms of the uncoupled ion permeation in health and disease, and ion-mediated regulation. We will combine bioinformatics, single-particle cryo-electron microscopy, single-molecule fluorescence microscopy, and other biophysical and biochemical approaches to pinpoint the residues, the conformational states, and the dynamic properties of transporters underlying their interactions with ions.
LOADING MOONBASE SCORE
Questions for WEILL MEDICAL COLL OF CORNELL UNIV
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · Weill Medical Coll of Cornell Univ63
Mechanistic Assessment of N-Acetylcysteine as an Antioxidant Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Through Dose Response and Treatment Target Engagement
Dikoma C Shungu · $525K · 2020–2026
- NIH · Weill Medical Coll of Cornell Univ53
Molecular Phenotyping and Image-Guidance for Surgical Treatment of High-Risk Prostate Cancer Using Ultrasmall Silica Nanoparticles
Michelle S Bradbury · $318K · 2023–2026
- NIH · Weill Medical Coll of Cornell Univ51
The Impact of Beta- and Gamma-Synucleins on Alpha-Synuclein's Synaptic Function
Jacqueline Burre · $783K · 2022–2027